Literature DB >> 2509813

A clinical biochemist's view of the investigation of suspected inherited metabolic disease.

W Blom1, J G Huijmans, G B van den Berg.   

Abstract

The necessity for a multi-disciplinary approach to the study of genetic disease is discussed. The progress of laboratory investigation programmes made it not feasible and inefficient to run a full metabolic investigation programme in every new patient suspected of inherited metabolic disease. An application form for metabolic investigation is described, which can be used to collect clinical information relevant to metabolic disease. On the basis of the patient's clinical information, selection criteria are given to decide which laboratory investigation programme has to be performed in the individual patient. A full metabolic laboratory investigation programme is described and illustrated with some examples of abnormal metabolite patterns. Diagnostic results over a 2-year period are presented.

Entities:  

Mesh:

Year:  1989        PMID: 2509813     DOI: 10.1007/978-94-009-1069-0_7

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

1.  Oligosaccharides in urine of patients with glycoprotein storage diseases. I. Rapid detection by thin-layer chromatography.

Authors:  R Humbel; M Collart
Journal:  Clin Chim Acta       Date:  1975-04-16       Impact factor: 3.786

2.  Prenatal diagnosis of inherited metabolic disorders by stable isotope dilution GC-MS analysis of metabolites in amniotic fluid: review of four years experience.

Authors:  C Jakobs
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

3.  Successful nicotinamide treatment in an autosomal dominant behavioral and psychiatric disorder.

Authors:  W Blom; G B van den Berg; J G Huijmans; J A Sanders-Woudstra
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

4.  Neurologic action of megadoses of vitamins.

Authors:  W Blom; G B van den Berg; J G Huijmans; H Przyrembel; J Fernandes; H R Scholte; J A Sanders-Woudstra
Journal:  Bibl Nutr Dieta       Date:  1986

5.  Morquio B syndrome: a primary defect in beta-galactosidase.

Authors:  G T van der Horst; W J Kleijer; A T Hoogeveen; J G Huijmans; W Blom; O P van Diggelen
Journal:  Am J Med Genet       Date:  1983-10

6.  Prenatal diagnosis of citrullinemia: elevated levels of citrulline in the amniotic fluid in the three affected pregnancies.

Authors:  W J Kleijer; W Blom; J G Huijmans; M C Mooyman; R Berger; M F Niermeijer
Journal:  Prenat Diagn       Date:  1984 Mar-Apr       Impact factor: 3.050

7.  Prenatal diagnosis of Sanfilippo disease type B.

Authors:  W J Kleijer; J G Huijmans; W Blom; D Gorska; J Kubalska; M Walasek; J Zaremba
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.

Authors:  C R Roe; D S Millington; D A Maltby; T P Bohan; S G Kahler; R A Chalmers
Journal:  Pediatr Res       Date:  1985-05       Impact factor: 3.756

9.  Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease.

Authors:  D S Millington; C R Roe; D A Maltby
Journal:  Biomed Mass Spectrom       Date:  1984-05

10.  alpha-N-acetylgalactosaminidase deficiency, a new lysosomal storage disorder.

Authors:  O P van Diggelen; D Schindler; R Willemsen; M Boer; W J Kleijer; J G Huijmans; W Blom; H Galjaard
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

View more
  3 in total

1.  Differential diagnosis of (inherited) amino acid metabolism or transport disorders.

Authors:  W Blom; J G Huijmans
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

2.  Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients.

Authors:  W Lehnert; W Sperl; T Suormala; E R Baumgartner
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

Review 3.  Selective screening for inborn errors of metabolism--past, present and future.

Authors:  G F Hoffmann
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.